The Global PCR and NGS-Based Molecular Diagnostics Market is expected to grow with a CAGR of 10% over the forecast period from 2022-2028.
Molecular diagnostics involves a variety of techniques that analyze biological markers in the genome and proteome. These technologies are used to guide patients’ rights from diagnosis to treatment of diseases such as cancer, infectious diseases and birth defects. These techniques help identify the genetic variation that caused the disease. Routinely used molecular diagnostic procedures include polymerase chain reaction (PCR), real-time PCR, restriction fragment length polymorphism analysis (RFLP), fluorescence in situ hybridization, gel electrophoresis, single-stranded conformational polymorphism, hybrid capture, and other assays.
(Get 15% Discount on Buying this Report)
A full report of Global PCR and NGS-Based Molecular Diagnostics Market is available at: https://orionmarketreports.com/pcr-and-ngs-based-molecular-diagnostics/82798/
Market Segments
By Product
- Reagents & Kits
- Instruments
- Services & Software
By Application
- Infectious Disease Diagnostics
- Genetic Tests
- Oncology Testing
- Others
Key Players
- Abbott
- Agilent Technologies, Inc.
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories, Inc.
- QIAGEN
- bioMérieux SA
- BD
- Illumina, Inc.
- Danaher
Scope of the Report
The research study analyzes the global PCR and NGS-Based Molecular Diagnostics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by PCR and NGS-Based Molecular Diagnostics Market Report
1. What was the PCR and NGS-Based Molecular Diagnostics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of PCR and NGS-Based Molecular Diagnostics Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the PCR and NGS-Based Molecular Diagnostics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global PCR and NGS-Based Molecular Diagnostics market.
- The market share of the global PCR and NGS-Based Molecular Diagnostics market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global PCR and NGS-Based Molecular Diagnostics market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global PCR and NGS-Based Molecular Diagnostics market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
